Taro Pharmaceutical IndusTARO
13F holders, Q4 2024 (December 31)3holders −3
1new positions
4sold out
$13.28avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Taro Pharmaceutical Indus (TARO) in their 13F filings, down 3 from Q3 2024. 1 opened new positions and 4 sold out. The largest holders were MassMutual Private Wealth & Trust, FSB ($3K), Versant Capital Management, Inc ($0) and Farther Finance Advisors, LLC ($0).
- Company
- Taro Pharmaceutical Indus
- CUSIP
- M8737E108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 4 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 44 shares bought and 2,201 shares sold, net −2,157 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| MassMutual Private Wealth & Trust, FSB | 0.00% | No change | 76 | $3K |
| Versant Capital Management, Inc | 0.00% | New | 44 | $0 |
| Farther Finance Advisors, LLC | 0.00% | No change | 126 | $0 |
"% of holder's portfolio" is TARO's weight in each manager's 13F, not the share of Taro Pharmaceutical Indus the manager owns.